There’s an increasing focus on using drugs to modify the tumour microenvironment, breaking down this blockade that supports tumour development and preventing penetration of cancer-killing immune ...

A new study from Cedars-Sinai Cancer reveals a potential way to overcome ... that share many characteristics with actual tumors. "We showed that inhibition of a gene called NPEPPS increased ...

A2A Pharmaceuticals, Inc. ("A2A or "the company"), a clinical-stage pioneering biopharmaceutical company focused on developing innovative cancer therapies, today announced significant progress in its ...